Trial Profile
Mie multicenter registry of hemodialysis patients undergoing PCI with drug-eluting stent
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Paclitaxel (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms MY HOPE
- 11 Dec 2015 Status changed from active, no longer recruiting to discontinued, as per University Hospital Medical Information Network - Japan record.
- 27 Jun 2013 New trial record